SpineGuard has announced that it has received the CE mark for the commercial release of its DSG Connect platform.
Already being utilised experimentally in a new strategic high value platform to guide surgical robots, SpineGuard will now apply this platform to its entire range of products, the company said in a press release. The attainment of the CE mark allows for the European launch of a new generation of PediGuard and “smart” screw devices equipped with the DSG Connect module, SpineGuard’s press release added.
DSG Connect is a tablet based software interface that adds visual interpretation to the auditory feedback for optimal exploitation of the signal during pedicle screw placement. It also allows for data recording of bone impedance values as evidence of optimal screw placement within the pedicle and for bone quality studies.
Stéphane Bette, co-founder and deputy CEO of SpineGuard, said: “SpineGuard affirms its willingness to continue innovation. DSG Connect is a major step in the development of the company and the deployment of the DSG technology, not only because of the commercial potential but also due to the strategic value of this new platform. On the business side, we will launch a new range of PediGuard devices in Europe offering advanced functionalities to spine surgeons upon resumption of the elective interventions postponed due to the COVID-19 pandemic.”